Add-on perampanel in Lance–Adams syndrome

Perampanel (PER) is the first-in-class selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist that has been licensed and marketed as antiepileptic drug (AED) indicated for patients with partial-onset and primary generalized tonic–clonic seizures. A...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Epilepsy Behav Case Rep
Huvudupphovsmän: Steinhoff, Bernhard J., Bacher, Matthias, Kurth, Christoph, Staack, Anke M., Kornmeier, Reinhold
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2016
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939387/
https://ncbi.nlm.nih.gov/pubmed/27437182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebcr.2016.05.001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk